Sweden Genome Editing Market Size & Outlook, 2024-2030
Sweden genome editing market, 2018-2030 (US$M)
Related Markets
Sweden genome editing market highlights
- The Sweden genome editing market generated a revenue of USD 110.0 million in 2023 and is expected to reach USD 322.0 million by 2030.
- The Sweden market is expected to grow at a CAGR of 16.6% from 2024 to 2030.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
Genome editing market data book summary
| Market revenue in 2023 | USD 110.0 million |
| Market revenue in 2030 | USD 322.0 million |
| Growth rate | 16.6% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Sweden accounted for 1.4% of the global genome editing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK genome editing market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 1,597.7 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 48.36% in 2024. Horizon Databook has segmented the Sweden genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
In Sweden, increased usage of genome editing in clinical practice for diagnosis and therapeutics development is anticipated to drive market growth. Sweden's genome editing market thrives due to its robust scientific infrastructure, supportive regulatory framework, and emphasis on sustainability & healthcare excellence.
With a focus on personalized medicine, there is a growing demand for advanced genetic tools. Collaboration among academia, industry, and government fuels innovation, aided by skilled workforce and venture capital.
Public-private partnerships and initiatives attract foreign investment. This collaboration is likely to propel Sweden to the forefront of genome editing, driving scientific advancement and economic growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Sweden genome editing market size, by technology, 2018-2030 (US$M)
Sweden Genome Editing Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
